Stockscreener 앱 받기
63.99
0.05%
-0.03
시간 외 거래:
63.99
전일 마감가:
$64.02
열려 있는:
$64.58
하루 거래량:
1.58M
Relative Volume:
0.49
시가총액:
$14.26B
수익:
$4.03B
순이익/손실:
$556.70M
주가수익비율:
27.00
EPS:
2.37
순현금흐름:
$970.10M
1주 성능:
-2.63%
1개월 성능:
+0.03%
6개월 성능:
-8.23%
1년 성능:
-17.60%
1일 변동 폭
$63.61
$64.64
1주일 범위
$63.22
$65.81
52주 변동 폭
$51.90
$84.67
홀로직 Stock (HOLX) Company Profile
명칭
Hologic Inc
전화
(508) 263-2900
주소
250 CAMPUS DRIVE, MARLBOROUGH, MA
HOLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
63.99 | 14.65B | 4.03B | 556.70M | 970.10M | 2.37 |
|
ISRG
Intuitive Surgical Inc
|
518.62 | 183.53B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
178.85 | 50.43B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.35 | 43.27B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
257.92 | 37.30B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
210.89 | 16.32B | 2.90B | 467.20M | 306.90M | 6.37 |
홀로직 Stock (HOLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-05-27 | 재확인 | Needham | Hold |
| 2025-03-03 | 다운그레이드 | Argus | Buy → Hold |
| 2025-02-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | 다운그레이드 | Needham | Buy → Hold |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-12-10 | 재확인 | Needham | Buy |
| 2024-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-06-27 | 개시 | Stephens | Overweight |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-14 | 업그레이드 | Needham | Hold → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-07-20 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-07-20 | 개시 | UBS | Neutral |
| 2022-07-18 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-07-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-11-20 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-05 | 재확인 | Needham | Buy |
| 2020-06-30 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-06-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | 재확인 | Needham | Buy |
| 2020-04-30 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | 재확인 | Needham | Buy |
| 2019-05-02 | 재확인 | Needham | Buy |
| 2019-01-31 | 재확인 | Needham | Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | 개시 | UBS | Neutral |
| 2018-09-13 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
홀로직 주식(HOLX)의 최신 뉴스
What analysts say about Hologic Inc. stockExplosive market performance - PrintWeekIndia
What drives Hologic Inc. stock pricePhenomenal investment performance - Autocar Professional
Is Hologic, Inc. (NASDAQ:HOLX) Trading At A 38% Discount? - simplywall.st
Hologic Inc. Stock Analysis and ForecastStrongest growth potential - Jammu Links News
Is Hologic Inc. a good long term investmentExplosive trading growth - Jammu Links News
Unexpected Trends Reshaping the Uterine Fibroid (UF) Treatment - openPR.com
Sentinel Node Biopsy Market Future Business Opportunities - openPR.com
Hologic Refinances Loan to Enhance Financial Flexibility - TipRanks
Hologic’s SWOT analysis: breast health recovery boosts stock outlook - Investing.com
What to Expect From Hologic's Q3 2025 Earnings Report - MSN
Cervical Dysplasia Market is Booming Worldwide |Hologic,Qiagen,Advaxis - openPR.com
Mizuho Raises Hologic Price Target to $70, Maintains Outperform Rating - AInvest
Hologic, Inc. (HOLX) Stock Forecasts - Yahoo Finance
Hologic (HOLX) Maintains Outperform Rating, Price Target Raised by Mizuho | HOLX Stock News - GuruFocus
Hologic Rides on AI-Powered Breast Health Innovations: What's Next? - Nasdaq
How the Computer Aided Detection Market Will Evolve by 2032 - openPR.com
Why Hologic (HOLX) Dipped More Than Broader Market Today - Yahoo Finance
Hologic, Inc. Fiscal Q3 2025 Earnings Release and ProjectionsNews and Statistics - IndexBox
Hologic's Q3 2025 Earnings: A Hidden Gem in Medtech Undervaluation - AInvest
Hologic Q3 2025 Earnings Report: Analyst Expectations and Stock Performance - AInvest
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
What makes Hologic Inc. stock price move sharplyDaily Top Gainers - beatles.ru
Hologic Maintains Strength in Diagnostics but Cuts to Medicaid Could Pressure Volume - Morningstar
Global Uterine Fibroids Treatment Devices Market to grow at - openPR.com
Hips & Knees Reconstructive Market Attracts 3D Implant - openPR.com
Hologic's GYN Surgical Dominance: What's Powering The Road Ahead? - Barchart.com
Hologic's GYN Surgical Dominance: What's Powering the Road Ahead? - The Globe and Mail
Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Citi upgrades Hologic stock rating to Buy on valuation and growth outlook - Investing.com Nigeria
Citigroup Upgrades Hologic (HOLX) with Revised Price Target | HO - GuruFocus
Citi upgrades Hologic stock rating to Buy on valuation and growth outlook By Investing.com - Investing.com South Africa
Hologic (HOLX) Upgraded by Citi with Increased Price Target | HOLX Stock News - GuruFocus
Citigroup Upgrades Hologic to Buy From Neutral, Adjusts Price Target to $80 From $60 - MarketScreener
Hologic (HOLX) Price Target Raised by Evercore ISI Group | HOLX Stock News - GuruFocus
Is Hologic Stock's Low Valuation an Opportunity or a Value Trap? - Nasdaq
The Price Is Right For Hologic, Inc. (NASDAQ:HOLX) - 富途牛牛
BioZorb Lawsuit LawyerBreast Biopsy Marker RecallJuly 2025 Update - Levin Papantonio
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - MSN
BioZorb Lawsuit and Settlement Information: July 2025 - AboutLawsuits.com
Hologic to Announce Financial Results for the Third Quarter of F - GuruFocus
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025 - MarketScreener
Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern - Yahoo
Hologic, Inc.(NasdaqGS: HOLX) dropped from Russell 1000 Dynamic Index - MarketScreener
How Hologic Leverages Its Financial Firepower to Drive Long-Term Value - Zacks Investment Research
Is Hologic, Inc. (NASDAQ:HOLX) Undervalued Despite Strong Growth Prospects? - AInvest
How Is Hologic’s Stock Performance Compared to Other Health Care Equipment Stocks? - Yahoo Finance
Hologic Joins NEST Governance Committee - Medical Product Outsourcing
From Now to 2032: Unpacking the Bone Mineral Densitometry - openPR.com
Global C-Arms Market Trends & Forecast 2025-2032 | Major - openPR.com
홀로직 (HOLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
자본화:
|
볼륨(24시간):